BR
Bode Ramachandra
About Bode Ramachandra
Bode Ramachandra has 10 years in corporate governance. Holds Director role. Formerly with 6 companies, such as Santosh Specialty Hospitals Private Limited and Kumar Hospitals Private Limited. Engaged in Technology, General Business and more. Contributes to corporate operations.
Current companies
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Santosh Specialty Hospitals Private Limited
U85100TN2015PTC100404
|
Director | 18 Nov 2015 | 2015 | Active |
Kumar Hospitals Private Limited
U85110AP2008PTC057083
|
Director | 24 Apr 2017 | 2008 | Active |
Mauryan Health Private Limited
U85310MH2016PTC283097
|
Additional Director | 24 Oct 2016 | 2016 | Strike Off |
Innoxen Technologies Private Limited
U74999KA2016PTC097224
|
Director | 19 Oct 2016 | 2016 | Strike Off |
Androvedic Organics Private Limited
U74999KA2016PTC097387
|
Director | 25 Oct 2016 | 2016 | Strike Off |
Lorik Healthsciences India Limited
U85100DL2018PLC334788
|
Director | 01 Jun 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bode Ramachandra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bode Ramachandra
Bode Ramachandra has 10 years in corporate governance. Holds Director role. Formerly with 6 companies, such as Santosh Specialty Hospitals Private Limited and Kumar Hospitals Private Limited. Engaged in Technology, General Business and more. Contributes to corporate operations.
Bode Ramachandra is associated with 0 companies as Director.
Bode Ramachandra has expertise in Technology, General Business and other sectors.
Bode Ramachandra has 10 years in corporate governance.